You can even adjust the colors and filters to create an eye-catching look. Then, add text, stickers, and other elements to make your cover stand out. For creating excellent-looking covers, simply upload your photos or choose from Fotor’s vast library of royalty-free stock photos. With rich elements and an intuitive interface, this is the perfect way to create a highlight cover for your Instagram. Therefore, whether you are using a personal account or business, your Instagram highlight covers need to be polished.įotor's Instagram highlight cover maker is designed for Instagram users to custom highlight covers. Moreover, organizing and customizing your profile with Instagram highlight cover photos is a great way to make a lasting impression on your followers. It allows you to share your favorite moments with others in a creative and fun way while making it easy for followers to find what they're looking for. The Instagram story highlight cover is an excellent feature. When you share a story, it becomes eligible to be a part of the Instagram highlight where it says forever. Laura Wood, Senior E.S.Free and Customizable Instagram Highlight Cover Template We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. is the world's leading source for international market research reports and market data. product information management).įor more information about this conference visit biosimilars), clinical development, regulatory convergence & harmonization and facilitated registration pathways (incl. In 2019, Marloes joined Qdossier. Marloes' areas of expertise are: eCTD, lean authoring, publishing, biopharmaceuticals (incl. Also, she contributed to the ongoing IMI PREFER project in Europe, focused on the generation and use of patient preference data. Marloes has been actively involved in several industry associations like EFPIA and IFPMA. For nine years she held several positions at Hoffmann-la Roche in Switzerland, including the role of regulatory intelligence manager and regulatory policy lead for the EMEA region. Marloes van der Geer works as senior regulatory affairs scientist at Qdossier. Marloes holds a master in Life Sciences (Drug Innovation) from the University of Utrecht, the Netherlands. He applies new technologies and Artificial Intelligence to facilitate the business and let people focus on what they can do best. He approaches interdisciplinary and international processes using that scientific background. He has gained a wealth of experience and a comprehensive view on what information is needed to evaluate the benefit/risk ratio of drugs for patients and healthy volunteers. in Pharmaceutical Medicine from the University of Surrey (UK) and has worked in the pharmaceutical industry for more than 35 years, primarily at global or European headquarters sites. Hans van Bruggen is CEO of and Senior Regulatory Affairs Scientist at Qdossier. annual reports, minor/major changes)Ī review of the main differences in terms of dossier content and procedures Lean authoring to ensure possible document re-use for multiple purposesīioresearch monitoring (BIMO) clinical dataĪ review of US amendment procedures (incl. Investigational New Drug (IND) Applications The purpose of the Common Technical Document (CTD) This programme will be especially beneficial to those responsible for preparing US registration documents (INDs, NDAs, Biologics License Applications, etc), regulatory affairs personnel, lawyers and others responsible for advising companies on strategies for developing new drugs for the US market. Understand FDA regulatory strategic needsĮnsure that you comply with FDA requirements for NDAs, ANDAs and 505(b)(2)ĭiscuss recent changes and developments with an industry expert and Improve your communication and interactions with the FDA Review the latest FDA regulatory requirements for drug development There will be ample opportunity for discussion with our expert trainer as well as other delegates and a practical workshop session to optimise learning. The course will emphasise areas of interest to innovative manufacturers, but will also deal with issues relating to generic and over-the-counter drugs. The comprehensive programme will cover procedures for submission of INDs, NDAs, ANDAs and 505(b)(2), provide a useful insight into the organisation and structure of the FDA and its review processes, and highlight recent changes. This course will help clarify the US regulatory process, giving you a practical insight into FDA requirements and ensuring that you are fully up to date with all the latest developments. The US is the largest market globally for pharmaceutical sales, so having a good understanding of FDA procedures is vital for those submitting in this challenging region.
0 Comments
Leave a Reply. |